Evotec

evotec.com · Hamburg-Nord, Germany

Evotec is a global drug discovery and development company that provides integrated research, preclinical, and early clinical services to pharmaceutical, biotechnology, and academic partners. It operates a network of research sites and platforms covering target discovery, hit identification, lead optimization, and biologics, generating revenue through fee-for-service contracts, strategic collaborations, and milestone and royalty agreements. The company focuses on accelerating the development of novel therapeutics across multiple disease areas, including neuroscience, oncology, metabolic, and infectious diseases.

Revenue
$650.0M
Employees
5,500
Founded
1993
Headquarters
Hamburg-Nord, Germany

What 10 Arbolus experts think of Evotec

The NPS distribution demonstrates a wide range from 3 to 10, with approximately 45% of responses in the Promoter range (NPS 9–10). Detractor sentiment sources primarily from high-spend Influencer roles, displaying notable churn risk. Renewal intent is split, with 30% confirming non-renewal, 20% not sure, and limited confirmations of ongoing contracts. Most implementations have exceeded the one-year threshold, with long-term Users reporting higher NPS and stickiness. Key themes are variability by spend level and high churn among Influencers.Overall Customer Sentiment: Neutral

Who reviewed Evotec

Total customers 10 10 current · 0 former
Reviews growth +10 in six months
Seniority of respondents
  • C-Suite 50% (5)
  • Director 30% (3)
  • Manager 20% (2)
Generalist Leader Director NPS 9 Undecided
Other Leader Manager NPS 7 Undecided
Operations Leader Director NPS 7

Employer names and spend open once the report publishes.

Tell us when the Evotec report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

20 Net Promoter Score, from 10 scored reviews
  • Promoters 4
  • Passives 4
  • Detractors 2

Cumulative NPS by month

+0 over 5 months
  • Jan 8
  • Feb 8
  • Apr 7
  • May 7
  • Jun 8

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 20 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 17%
  • Will renew 1
  • Undecided 3
  • Not renewing 2

Plan to renew, by seniority

  • C-Suite 50% 2 answers
  • Director 0% 2 answers
  • Manager 0% 2 answers
  • 8/10 Average score from customers who will renew
  • 8.3/10 Average score from undecided customers
  • 5.5/10 Average score from customers not renewing

For people who use Evotec

Do you use Evotec at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 10 customers of Evotec have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.